NGN Capital

NGN Capital

NGN Capital is a New York City based venture capital firm focused on investments in healthcare and biotechnology companies in the United States and Europe.

NGN Capital is a New York City based venture capital firm. They invest in the healthcare and biotechnology companies including drug products, medical devices and healthcare services sectors. NGN Capital focuses their investments on companies they feel have the potential to achieve above average equity returns.

NGN Capital invests across maturity stages, from seed and early stage to later stage, and predominately in the United States and Europe. Their European office is in Heidelberg, Germany.

Investment

NGN Capital has invested in Exosome Diagnostics, Endosense, Small Bone Innovations, Artisan Pharma, Noxxon Pharma, Valtech Cardio, BeneChill, Aerovance, Cerapedics and Vivaldi Biosciences.

They exited their investments in Exosome Diagnostics, Small Bone Innovations, Noxxon Pharma, Santhera Pharmaceuticals, Endosense, BeneChill, Valtech Cardio and EKOS Corporation.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Exosome Diagnostics

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

Biotechnology
New York
Cerapedics

Cerapedics is a Westminster, Colorado-based healthcare company.

Healthcare
Westminster, Colorado
Endosense

Valtech Cardio

4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alexander Cuomo

Chief Financial Officer

John R. Constantino

Managing General Partner

Kenneth J. Gorelick

Venture Partner

Kenneth S. Abramowitz

Managing General Partner

Peter Johann

Managing General Partner

William J. Gedale

Senior Advisor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.